Kartos Therapeutics
Operator of a biopharmaceutical company intended to offer investigational MDM2 inhibitor for cancer treatment.
Drug Discovery
📍 Redwood City, CA
Founded 2018
Current Valuation
$700M
as of 2020-Q1
PRIVATE
Operator of a biopharmaceutical company intended to offer investigational MDM2 inhibitor for cancer treatment.
Company Profile
Last Round
Series B — $90M (Jan 2020)
Fundraising Status
Series B · $90M · 6y 5mo ago
privateTotal raised $115M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $90M | Jan 2020 | — | $700M |
Biotechnology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2020-Q1. Refreshed quarterly.